NCT00400959View on ClinicalTrials.gov

CD133+ Autologous Cells After Myocardial Infarction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

October 31, 2006

Conditions
Acute Myocardial Infarction
Interventions
PROCEDURE

cd133+cell intracoronary administration

Trial Locations (1)

Unknown

Cell Factory, department of regenerative medicine, Policlinic of Milan, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

NCT00400959 - CD133+ Autologous Cells After Myocardial Infarction | Biotech Hunter | Biotech Hunter